ETV6 and congenital fibrosarcoma: Notably, FISH is highly effective for identifying ETV6-NTRK3 fusions, which enables its good application in mammary analog secretory carcinoma, infantile fibrosarcoma, and congenital mesoblastic nephroma (52, 62).